Prostatic edema in 125I permanent prostate implants: dynamical dosimetry taking volume changes into account.
The purpose of this study is to determine the impact of edema on the dose delivered to the target volume. An evaluation of the edema characteristics was first made, and then a dynamical dosimetry algorithm was developed and used to compare its results to a standard clinical (static) dosimetry. Source positions and prostate contours extracted from 66 clinical cases on images taken at different points in time (planning, implant day, post-implant evaluation) were used, via the mean interseed distance, to characterize edema [initial increase (deltar0), half-life (tau)]. An algorithm was developed to take into account the edema by summing a time series of dose-volume histograms (DVHs) with a weight based on the fraction of the dose delivered during the time interval considered. The algorithm was then used to evaluate the impact of edema on the dosimetry of permanent implants by comparing its results to those of a standard clinical dosimetry. The volumetric study yielded results as follows: the initial prostate volume increase was found to be 1.58 (ranging from 1.15 to 2.48) and the edema half-life, approximately 30 days (range: 3 to 170 days). The dosimetric differences in D90 observed between the dynamic dosimetry and the clinical one for a single case were up to 15 Gy and depended on the edema half-life and the initial volume increase. The average edema half-life, 30 days, is about 3 times longer than the previously reported 9 days. Dosimetric differences up to 10% of the prescription dose are observed, which can lead to differences in the quality assertion of an implant. The study of individual patient edema resorption with time might be necessary to extract meaningful clinical correlation or biological parameters in permanent implants.
Leclerc
Ghyslain
G
Département de Physique, de Génie Physique et d'Optique, Université Laval, Québec, Canada.
Lavallée
Marie-Claude
MC
Roy
René
R
Vigneault
Eric
E
Beaulieu
Luc
L
D000465:Algorithms; D001918:Brachytherapy / Q000379:methods*; D004487:Edema / Q000000981:diagnostic imaging* / Q000473:pathology / Q000532:radiotherapy; D006207:Half-Life; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008954:Models, Biological; D011469:Prostatic Diseases / Q000000981:diagnostic imaging / Q000473:pathology / Q000532:radiotherapy*; D019919:Prosthesis Implantation; D011874:Radiometry / Q000379:methods*; D011877:Radionuclide Imaging; D011879:Radiotherapy Dosage; D018570:Risk Assessment; D013997:Time Factors
D007457:Iodine Radioisotopes